Loading...
Who Supplies Paclitaxel to India from SOUTH KOREA
India's paclitaxel imports from SOUTH KOREA total $1.6B across 27 shipments from 1 foreign suppliers. SAMYANG HOLDINGS CORPORATION leads with $1.6B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include LUPIN LIMITED. This corridor reflects India's pharmaceutical import demand for paclitaxel — a concentrated sourcing relationship with select suppliers from SOUTH KOREA.
Top foreign suppliers (SOUTH KOREA) — Ranked by import value
SAMYANG HOLDINGS CORPORATION is the leading Paclitaxel supplier from SOUTH KOREA to India, with import value of $1.6B across 27 shipments. The top 5 suppliers — SAMYANG HOLDINGS CORPORATION — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (SOUTH KOREA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SAMYANG HOLDINGS CORPORATION | $1.6B | 27 | 100.0% |
Showing top 1 of foreign suppliers · Indian Customs (DGFT) · TransData Nexus